Search Results - "Leticia O. Marani"

ABSENT CD33 IN AML PATIENTS: FROM DIAGNOSIS TO FOLLOW-UPS by Leticia O. Marani, Amanda Costa, Fernanda B. Silva, Maria Izabel A. Madeira, Priscila S. Scheucher, Josiane L.S. Schiavinato, Ana Silvia G. Lima, Katia B.B. Pagnano, Bruno K. Duarte, Sylvie Freeman, Eduardo M. Rego, Fabiola Traina, Lorena L. Figueiredo-Pontes

“…Background: Despite recent advances and development of new therapeutic targets and personalized medicine, acute myeloid leukemia (AML) treatment remains…”
Get full text

International Expansion of Modern AML Therapy by Figueiredo-Pontes, Lorena L., Traina, Fabiola, Ayrosa, Maria Isabel, Marani, Leticia O., Fernandes, Amanda, Rego, Eduardo M.

Get full text

Imbalanced receptors, gene signatures, and function of NK subsets predicts poor clinical outcomes in AML by Costa, Amanda, Kuznetsova, Valeriya, Marani, Leticia O., Lopes, Izabela A., Binelli, Larissa S., Scheucher, Priscila S., Schiavinato, Josiane L., Madeira, Maria Isabel A., Pagnano, Katia B., Duarte, Bruno K., Glória, Ana Beatriz F., Rego, Eduardo M., Traina, Fabíola, Figueiredo-Pontes, Lorena L., Welner, Robert

“…Abstract NK cells mediate anti-leukemic immunosurveillance in AML. We hypothesized that impaired NK cells predict poor outcomes in AML. We analyzed the…”
Get full text

Dysregulated Activating and Inhibitory Receptors on Natural Killer Cells Predicts Immune Escape and Poor Outcomes in Acute Myeloid Leukemia by Costa, Amanda F O, Kuznetsova, Valeriya, Marani, Leticia O, Lopes, Izabela A, Binelli, Larissa S, Scheucher, Priscila S, Schiavinato, Josiane L, Faria, Joana T B, Madeira, Maria Isabel A, Pagnano, Katia B, Duarte, Bruno K, Gloria, Ana Beatriz F, Rego, Eduardo M, Traina, Fabiola, Welner, Robert, Figueiredo-Pontes, Lorena L

Get full text